- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide
Total 1120 results
-
University of PennsylvaniaCelgene CorporationCompletedCutaneous Lupus Erythematosus (CLE)United States
-
Rennes University HospitalCompleted
-
Ohio State University Comprehensive Cancer CenterCureTech LtdTerminatedMultiple MyelomaUnited States
-
Karyopharm Therapeutics IncCompletedMultiple MyelomaUnited States, Belgium, Austria, France, Germany, Greece
-
Karyopharm Therapeutics IncWithdrawn
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
Second Affiliated Hospital of Soochow UniversityEnrolling by invitationDiffuse Large B-cell LymphomaChina
-
Medical College of WisconsinWithdrawnAdvanced Breast Cancer | Solid TumorUnited States
-
University College, LondonCancer Research UK; CelgeneActive, not recruitingPlasmacytomaUnited Kingdom
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Attaya SuvannasankhaJanssen Scientific Affairs, LLC; Indiana Institute for Medical ResearchWithdrawnMultiple MyelomaUnited States
-
Second Affiliated Hospital, School of Medicine,...CompletedPrimary Central Nervous System LymphomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Alkylating Agent-Related Acute Myeloid LeukemiaUnited States
-
AmgenTerminated
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMucosa Associated Lymphoid Tissue (MALT) LymphomaSpain, Italy, Austria
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
University of Michigan Rogel Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Yazeed SawalhaWithdrawnRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular... and other conditions
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
TakedaCompleted
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Brian HillThe Cleveland ClinicTerminatedLymphoma | B Cell LymphomaUnited States
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Fondazione Italiana Linfomi ONLUSActive, not recruiting
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruiting
-
MorphoSys AGCompletedDiffuse Large B Cell LymphomaFrance, Italy, United States, Spain
-
Maria LiljeforsKarolinska University Hospital; Karolinska Institutet; CelgeneCompletedPancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma MetastaticSweden
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
Molecular Templates, Inc.Terminated
-
Ciusss de L'Est de l'Île de MontréalCelgene; C3i Center Inc.Active, not recruitingMultiple Myeloma | Relapsed Hematologic MalignancyCanada
-
Hackensack Meridian HealthCelgene CorporationTerminatedSmall Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia(CLL)United States
-
Swiss Group for Clinical Cancer ResearchTerminatedMultiple MyelomaSwitzerland, Italy
-
University of California, San DiegoCompletedCLL | Richter's SyndromeUnited States
-
CelgeneCompleted
-
Bristol-Myers SquibbAbbVieCompleted
-
CelgeneActive, not recruitingMultiple MyelomaNetherlands, Belgium, Denmark, Germany, United Kingdom, France, Norway, Spain, Austria, Ireland, Italy, Sweden
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States